G&E Herbal Biotechnology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
G&E Herbal Biotechnology has a total shareholder equity of NT$774.6M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$874.9M and NT$100.2M respectively. G&E Herbal Biotechnology's EBIT is NT$93.4M making its interest coverage ratio -16.9. It has cash and short-term investments of NT$324.1M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
NT$0
Borç
| Faiz karşılama oranı | -16.9x |
| Nakit | NT$324.13m |
| Eşitlik | NT$774.65m |
| Toplam yükümlülükler | NT$100.22m |
| Toplam varlıklar | NT$874.86m |
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 4911's short term assets (NT$357.3M) exceed its short term liabilities (NT$98.9M).
Uzun Vadeli Yükümlülükler: 4911's short term assets (NT$357.3M) exceed its long term liabilities (NT$1.3M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 4911 is debt free.
Borcun Azaltılması: 4911 has not had any debt for past 5 years.
Borç Kapsamı: 4911 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 4911 has no debt, therefore coverage of interest payments is not a concern.